All 3,750 procedure codes billed by Medicaid providers in Connecticut, ranked by total spending.
| # | Code | Description | Total Paid |
|---|---|---|---|
| 1 | T1015 | Clinic visit/encounter, all-inclusive | $1.75B |
| 2 | 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | $758.99M |
| 3 | T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | $644.50M |
| 4 | 99284 | Emergency department visit for the evaluation and management, high severity | $597.32M |
| 5 | 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | $527.23M |
| 6 | 90837 | Psychotherapy, 53 minutes with patient | $441.22M |
| 7 | 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | $417.03M |
| 8 | 99283 | Emergency department visit for the evaluation and management, moderate severity | $387.80M |
| 9 | H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | $381.71M |
| 10 | G0463 | Hospital outpatient clinic visit for assessment and management of a patient | $278.38M |
| 11 | S9124 | Nursing care, in the home; by licensed practical nurse, per hour | $231.01M |
| 12 | S9123 | Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used) | $212.09M |
| 13 | 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | $186.99M |
| 14 | T1004 | Services of a qualified nursing aide, up to 15 minutes | $177.55M |
| 15 | A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | $164.45M |
| 16 | H2036 | Alcohol and/or other drug treatment program, per diem | $138.93M |
| 17 | 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | $135.38M |
| 18 | 5140Z | $134.70M | |
| 19 | H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | $119.43M |
| 20 | H2019 | Therapeutic behavioral services, per 15 minutes | $114.07M |
| 21 | 90834 | Psychotherapy, 45 minutes with patient | $112.66M |
| 22 | A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | $100.17M |
| 23 | J2350 | Injection, ocrelizumab, 1 mg | $86.49M |
| 24 | 90832 | Psychotherapy, 30 minutes with patient | $83.12M |
| 25 | D1120 | Prophylaxis - child | $79.00M |
| 26 | S9480 | Intensive outpatient psychiatric services, per diem | $74.10M |
| 27 | 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | $72.05M |
| 28 | 74177 | Computed tomography, abdomen and pelvis; with contrast material | $70.59M |
| 29 | D0120 | Periodic oral evaluation - established patient | $58.74M |
| 30 | T2048 | Behavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem | $58.05M |
| 31 | J9271 | Injection, pembrolizumab, 1 mg | $57.91M |
| 32 | 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | $57.13M |
| 33 | D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | $56.00M |
| 34 | 1021Z | $54.98M | |
| 35 | 90853 | Group psychotherapy (other than of a multiple-family group) | $54.33M |
| 36 | 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | $54.13M |
| 37 | 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | $53.28M |
| 38 | 99282 | Emergency department visit for the evaluation and management, low to moderate severity | $52.65M |
| 39 | 92015 | Determination of refractive state | $52.29M |
| 40 | 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | $52.00M |
| 41 | 90791 | Psychiatric diagnostic evaluation | $50.47M |
| 42 | 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | $49.13M |
| 43 | 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | $48.10M |
| 44 | H0011 | Alcohol and/or drug services; acute detoxification (residential addiction program inpatient) | $47.95M |
| 45 | U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $46.72M |
| 46 | A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | $46.22M |
| 47 | J0178 | Injection, aflibercept, 1 mg | $45.96M |
| 48 | 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | $45.73M |
| 49 | 97153 | Adaptive behavior treatment by protocol, administered by technician, each 15 minutes | $45.23M |
| 50 | 71046 | Radiologic examination, chest; 2 views | $43.78M |
| 51 | 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | $42.82M |
| 52 | S0215 | Non-emergency transportation; mileage, per mile | $42.23M |
| 53 | D8670 | Periodic orthodontic treatment visit | $41.73M |
| 54 | 45380 | Colonoscopy, flexible; with biopsy, single or multiple | $41.36M |
| 55 | 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | $40.22M |
| 56 | 5140Y | $39.07M | |
| 57 | 90460 | Immunization administration through 18 years of age via any route, first or only component | $38.90M |
| 58 | 99215 | Prolong outpt/office vis | $37.79M |
| 59 | 96361 | Intravenous infusion, hydration; each additional hour | $37.78M |
| 60 | D1208 | Topical application of fluoride, excluding varnish | $37.04M |
| 61 | J1745 | Injection, infliximab, excludes biosimilar, 10 mg | $36.95M |
| 62 | 70450 | Computed tomography, head or brain; without contrast material | $36.91M |
| 63 | 88305 | Level IV - Surgical pathology, gross and microscopic examination | $36.54M |
| 64 | 95810 | Polysomnography; sleep staging with 4 or more additional parameters | $35.73M |
| 65 | 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | $33.98M |
| 66 | A0100 | Non-emergency transportation; taxi | $33.94M |
| 67 | 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | $32.95M |
| 68 | G0162 | Skilled services by a registered nurse (rn) for management and evaluation of the plan of care; each 15 minutes (the patient's underlying condition or complication requires an rn to ensure that essential non-skilled care achieves its purpose in the home health or hospice setting) | $32.23M |
| 69 | 97530 | Therapeutic activities, direct patient contact, each 15 minutes | $31.54M |
| 70 | 99232 | Subsequent hospital care, per day, moderate complexity | $30.98M |
| 71 | 90847 | Family psychotherapy with the patient present, 50 minutes | $30.94M |
| 72 | 77067 | Screening mammography, bilateral, including computer-aided detection | $30.85M |
| 73 | 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | $30.74M |
| 74 | D2391 | Resin-based composite - one surface, posterior, primary or permanent | $29.36M |
| 75 | 96375 | Therapeutic injection; each additional sequential IV push | $29.03M |
| 76 | 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | $28.21M |
| 77 | 99309 | Subsequent nursing facility care, per day, low to moderate complexity | $27.83M |
| 78 | 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | $27.21M |
| 79 | V2020 | Frames, purchases | $27.17M |
| 80 | 59025 | Fetal non-stress test | $26.82M |
| 81 | 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | $26.58M |
| 82 | 90999 | Unlisted dialysis procedure, inpatient or outpatient | $25.45M |
| 83 | D0274 | Bitewings - four radiographic images | $25.29M |
| 84 | D0150 | Comprehensive oral evaluation - new or established patient | $24.53M |
| 85 | 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | $24.48M |
| 86 | D1110 | Prophylaxis - adult | $24.46M |
| 87 | J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | $24.02M |
| 88 | 1286Z | $23.99M | |
| 89 | J2323 | Injection, natalizumab, 1 mg | $23.80M |
| 90 | D0140 | Limited oral evaluation - problem focused | $23.18M |
| 91 | 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | $22.84M |
| 92 | 1201Z | $22.08M | |
| 93 | 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | $21.36M |
| 94 | T1017 | Targeted case management, each 15 minutes | $21.24M |
| 95 | D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | $20.38M |
| 96 | 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | $20.24M |
| 97 | 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | $20.11M |
| 98 | 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | $20.09M |
| 99 | 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | $20.00M |
| 100 | 74176 | Computed tomography, abdomen and pelvis; without contrast material | $19.90M |
| 101 | 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | $19.90M |
| 102 | 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | $19.89M |
| 103 | H0035 | Mental health partial hospitalization, treatment, less than 24 hours | $19.62M |
| 104 | J0585 | Injection, onabotulinumtoxina, 1 unit | $19.26M |
| 105 | 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | $18.87M |
| 106 | 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | $18.78M |
| 107 | 71045 | Radiologic examination, chest; single view | $18.51M |
| 108 | D1206 | Topical application of fluoride varnish | $18.44M |
| 109 | 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | $18.27M |
| 110 | A0425 | Ground mileage, per statute mile | $18.14M |
| 111 | G0384 | Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | $18.05M |
| 112 | 99233 | Prolong inpt eval add15 m | $17.74M |
| 113 | D0330 | Panoramic radiographic image | $17.72M |
| 114 | H2034 | Alcohol and/or drug abuse halfway house services, per diem | $17.20M |
| 115 | J3357 | Ustekinumab, for subcutaneous injection, 1 mg | $17.13M |
| 116 | D7140 | Extraction, erupted tooth or exposed root | $16.86M |
| 117 | 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | $16.65M |
| 118 | 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | $16.56M |
| 119 | 97010 | $16.25M | |
| 120 | 92340 | Fitting of spectacles, except for aphakia; monofocal | $16.23M |
| 121 | G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | $16.20M |
| 122 | K0553 | Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | $16.01M |
| 123 | 76705 | Ultrasound, abdominal, real time with image documentation; limited | $15.83M |
| 124 | 99308 | Subsequent nursing facility care, per day, straightforward | $15.73M |
| 125 | U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | $15.69M |
| 126 | H2012 | Behavioral health day treatment, per hour | $15.55M |
| 127 | A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | $15.18M |
| 128 | 1023Z | $15.11M | |
| 129 | V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | $14.69M |
| 130 | 76830 | Ultrasound, transvaginal | $14.66M |
| 131 | 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | $14.65M |
| 132 | 71260 | Computed tomography, thorax, diagnostic; with contrast material | $14.05M |
| 133 | H2013 | Psychiatric health facility service, per diem | $13.79M |
| 134 | U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | $13.70M |
| 135 | D1351 | Sealant - per tooth | $13.54M |
| 136 | 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | $13.51M |
| 137 | J9299 | Injection, nivolumab, 1 mg | $13.40M |
| 138 | J3380 | Injection, vedolizumab, intravenous, 1 mg | $13.06M |
| 139 | 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | $13.03M |
| 140 | J2357 | Injection, omalizumab, 5 mg | $12.86M |
| 141 | 47562 | $12.61M | |
| 142 | 78815 | Positron emission tomography (PET) for limited area imaging | $12.60M |
| 143 | 96131 | $12.21M | |
| 144 | 5140X | $12.10M | |
| 145 | 96127 | $12.08M | |
| 146 | D2930 | Prefabricated stainless steel crown - primary tooth | $12.07M |
| 147 | D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | $12.05M |
| 148 | 97161 | $12.04M | |
| 149 | S0580 | Polycarbonate lens (list this code in addition to the basic code for the lens) | $11.94M |
| 150 | 93975 | $11.88M | |
| 151 | A4239 | Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | $11.59M |
| 152 | D0272 | Bitewings - two radiographic images | $11.46M |
| 153 | B4035 | Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape | $11.40M |
| 154 | 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | $11.12M |
| 155 | E1161 | Manual adult size wheelchair, includes tilt in space | $11.00M |
| 156 | T4541 | Incontinence product, disposable underpad, large, each | $10.99M |
| 157 | E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | $10.97M |
| 158 | D0210 | Intraoral - complete series of radiographic images | $10.88M |
| 159 | 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | $10.60M |
| 160 | 72125 | Computed tomography, cervical spine; without contrast material | $10.50M |
| 161 | D0220 | Intraoral - periapical first radiographic image | $10.40M |
| 162 | 90792 | Psychiatric diagnostic evaluation with medical services | $10.38M |
| 163 | 92250 | $10.38M | |
| 164 | G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | $10.22M |
| 165 | J0897 | Injection, denosumab, 1 mg | $10.16M |
| 166 | D9223 | Deep sedation/general anesthesia - each subsequent 15 minute increment | $10.09M |
| 167 | T1019 | Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant) | $10.06M |
| 168 | D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | $9.98M |
| 169 | 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | $9.91M |
| 170 | J2505 | Injection, pegfilgrastim, 6 mg | $9.85M |
| 171 | 93458 | $9.67M | |
| 172 | 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | $9.62M |
| 173 | 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | $9.50M |
| 174 | J9312 | Injection, rituximab, 10 mg | $9.48M |
| 175 | 76641 | $9.41M | |
| 176 | 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | $9.25M |
| 177 | G0379 | Direct admission of patient for hospital observation care | $9.17M |
| 178 | 99244 | Office or other outpatient consultation, moderate to high complexity | $9.11M |
| 179 | 76801 | $9.09M | |
| 180 | 71275 | Computed tomographic angiography, chest, with contrast material | $9.05M |
| 181 | G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | $8.98M |
| 182 | 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | $8.98M |
| 183 | 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | $8.91M |
| 184 | 92587 | $8.80M | |
| 185 | 95811 | $8.69M | |
| 186 | 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | $8.65M |
| 187 | 2074Y | $8.63M | |
| 188 | 93971 | $8.60M | |
| 189 | 86900 | $8.50M | |
| 190 | 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | $8.49M |
| 191 | 99223 | Prolong inpt eval add15 m | $8.42M |
| 192 | H0046 | Mental health services, not otherwise specified | $8.42M |
| 193 | 97162 | $8.38M | |
| 194 | 27447 | $8.33M | |
| 195 | J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | $8.15M |
| 196 | T1001 | Nursing assessment / evaluation | $8.15M |
| 197 | D7240 | Removal of impacted tooth - completely bony | $8.09M |
| 198 | 76700 | Ultrasound, abdominal, real time with image documentation; complete | $8.04M |
| 199 | T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | $8.02M |
| 200 | 70551 | Magnetic resonance imaging, brain; without contrast material | $7.99M |